Evidence-Based Oncology > July 2019

Evidence-Based Oncology - July 2019

July 15, 2019 – Jaime Rosenberg, Mary Caffrey, Allison Inserro
Clinical findings presented at the 2019 Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois.
July 15, 2019 – Samantha DiGrande
Real-world evidence is being embraced by FDA as a way to expand the review of data beyond the trial population, which may not be representative of the patients seen in clinics on a daily basis.
July 15, 2019 – Samantha DiGrande
Cytokine release syndrome represents a major concern, and source of costs, associated with the life-saving gene therapy.
July 15, 2019 – Samantha DiGrande
From the Oncology Care Model to the possibilities of cannabis, policy issues drew big crowds at the 2019 Annual Meeting of the American Society of Clinical Oncology.
July 16, 2019 – Kelly Davio
Research on biosimilars presented at the 2019 Annual Meeting of the American Society of Clinical Oncology.
July 16, 2019 – Jaime Rosenberg and Wallace Stephens
Selected abstracts from the 2019 Annual Meeting of the American Society of Clinical Oncology. 
July 16, 2019 – Laura Joszt, Jaime Rosenberg, Allison Inserro, Mary Caffrey, Samantha DiGrande
Financial toxicity, ACO contracts, removing barriers to care.
July 16, 2019 – Produced by Jaime Rosenberg and Samantha DiGrande
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.